White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Orphan drugs revisited:[comment]

Claxton, K. (orcid.org/0000-0003-2002-4694), Raftery, J., McCabe, C. and Tsuchiya, A. (2006) Orphan drugs revisited:[comment]. QJM Monthly Journal of the Association of Physicians. discussion 350. pp. 341-5. ISSN 1460-2725

Text (McCabeetalQJM2006_open_access.pdf)

Download (64Kb)


Hughes et al.1 recently discussed arguments for and against giving special funding status to orphan drugs in this journal. They concluded that there should be a uniform policy across Europe, that complete restriction was impractical, and that UK policy should aspire to the values of the EU directive. The aims of this paper are to correct some inaccuracies in the original paper, develop some of the key issues, and to draw some conclusions regarding the question ‘Do drugs for exceptionally rare disease deserve special status for funding?’ For ease, our paper adopts the same structure as the original.

Item Type: Article
Copyright, Publisher and Additional Information: © The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Keywords: Attitude of Health PersonnelEthics,MedicalEuropeHumansLegislation,Drug/es [Ethics]*Orphan Drug Production/ec [Economics]Orphan Drug Production/es [Ethics]Orphan Drug Production/lj [Legislation & Jurisprudence]*Rare Diseases/dt [Drug Therapy]Rare Diseases/ec [Economics],RARE DISEASES
Institution: The University of York
Academic Units: The University of York > Economics and Related Studies (York)
Depositing User: Mrs JM Wright
Date Deposited: 13 Dec 2007 13:42
Last Modified: 14 Jun 2016 09:01
Published Version: http://dx.doi.org/10.1093/qjmed/hcl033
Status: Published
Refereed: Yes
URI: http://eprints.whiterose.ac.uk/id/eprint/3532

Actions (repository staff only: login required)